Nomination committee in IRLAB appointed
IRLAB announced today that in preparation for the annual general meeting 2020, the company’s three largest shareholders, or groups of shareholders, have appointed members of the nomination committee. The nomination committee consists of Bo Rydlinger, Daniel Johnsson and Clas Sonesson beside Anders Vedin, the chairman of the board. The nomination committee represents about 57 percent of shares and votes in the company.According to the instruction for appointment of the nomination committee in IRLAB Therapeutics AB, resolved at the annual general meeting on April 25, 2019, the nomination